Previously, Mr. Bergy served as vice president of finance and chief accounting officer, vice president of finance for the medical division and corporate controller at Stryker.
He will be up for re-election in 2012.
Read the RTI Biologics release on Dean Bergy.
Read other coverage on RTI Biotics.
-RTI Biologics Develops Reimbursement Hotline for Sports Medicine
-RTI Biologics Posts 11% Higher Revenues in Third Quarter, a Record
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
